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Summary 
 
A workshop involving the DDDAC – RVF case study team, medical and laboratory officers from the health 
centers in the project sites (Garissa, Ijara, Sangailu, Hola and Bura) and enumerators hired by the project 
to conduct questionnaire surveys was convened in Garissa on 4th to 7th December in The Nomad hotel, 
Garissa (the list of participants is given in Annex II). The workshop aimed to (i) review the objectives, 
design, the expected benefits and ethical requirements of the human health component of the DDDAC – 
RVF case study and (ii) develop work plans and implementation teams. The meeting was officially 
opened by the Garissa Country Director of Medical Services. 
In the first day of the meeting, the DDDAC project team took the participants through the objectives and 
the design of the project, and the reasons why their area had been chosen as a study site. The 
participants were were informed that the area had been chosen because it is one of the areas in Kenya 
that is undergoing land use changes through irrigation. The project team described some of the 
expected linkages between irrigation and human health risks. The session also reviewed alternative 
vector-borne and zoonotic diseases that the local health centres needed to consider while making 
differential diagnosis of febrile conditions given that they presented similar symptoms.    
A study guide that had been developed for the human health study (made up of community and 
hospital-based surveys) was presented and discussed in detail. The project team highlighted the roles 
that each medical and laboratory technician would play in the survey. On the second day of the 
workshop, discussions on the RVF study guide were succeeded by those of the standard ethical 
principles that guide research on human subjects including: 
• Autonomy – researchers must allow potential subjects make independent choices on their 
participation. The investigator must ensure that: the participant has received a full disclosure of 
the nature of the study, the risks, benefits and alternatives, with an extended opportunity to ask 
questions 
• Beneficence -- the investigator must attempt to maximize benefits for the individual participant 
and/or society, while minimizing risk of harm to the individual 
• Justice – equitable selection of participants, benefits or burdens among groups likely to 
participate in research  
The process of obtaining informed consent was also discussed. It was agreed that various stages of 
consent needed to be used starting with obtaining consent from the community gate keepers, followed 
by those of the household heads and the specific participants that were to be sampled. 
The third and the fourth day of the workshop focussed on the development of work plans and the fifth 
day was devoted for pretesting the questionnaires that were to be used to collect subjects’ metadata.  
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1 Background 
 
The Rif Valley fever (RVF) case study is being implemented by ILRI in partnership with the Division of 
Disease Surveillance and Response (DDSR), Kenya Medical Research Institute (KEMRI), Department of 
Veterinary Services (DVS), the School of Biological studies and the Institute of Anthropology, Gender and 
African Studies, University of Nairobi (UoN) and the, Ministry of Public Health and Sanitation. The case 
study investigates whether land use change (through irrigation) promotes the occurrence and 
persistence of RVF. The case study has several components including human health, livestock health, 
entomology, ecology, socio-economics and anthropology. Study sites that have been identified for the 
work include Ijara division in Ijara district, Bura and Hola irrigation schemes in Tana River district. The 
case study also intends to screen for other diseases that present similar signs as RVF (including Crimean-
Congo Haemorrhagic Fever (CCHF) virus, yellow fever virus, Dengue fever virus, Ngari virus; Chikungunya 
Brucella spp. [brucellosis], Coxiella burnetii [Q fever] and Leptospira spp. and malaria) in order to 
generate data that can be used to build capacity on differential diagnosis of febrile illnesses in the area.  
A workshop was convened in Garissa to develop plans for the initiation of the human health component.   
2 Workshop sessions 
2.1 Review of the case study guide 
 
The objectives and design of the human component of the RVF case study 
 
This session commenced with a review of the DDDAC research questions including: 
• How do ecological changes as shaped by human-ecosystem interactions affect pathogen 
dynamics and hence the likelihood of zoonotic spillover and transmission? 
• How do different peoples’ interactions with ecosystems affects their exposure to the disease?  
• What are the impacts of the disease on poverty and well-being,  
• How do regional, national and global drivers (e.g. climate, land use, population, urbanization, 
economy) shape these local dynamics,  
• How do different actors (local people, government agencies, policy-makers) understand and 
represent (‘frame’) ecosystem services and related health problems within a political economy 
of knowledge, and how does this shape their practices and interventions?  
 
This was followed by a review of the objectives of the human component of the RVF case study:  
1. To determine whether land use changes associated with the development of irrigation schemes 
promotes the occurrence and persistence of Rift Valley fever (RVF) in people and livestock 
2. To determine relative prevalence of pathogens that should be considered for differential 
diagnosis of febrile diseases in humans 
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– hemorrhagic fever viruses (Crimean-Congo Haemorrhagic Fever (CCHF) virus, yellow 
fever virus, Dengue fever virus, and Ngari virus);  
– other important arboviruses (e.g., Chikungunya virus); 
–  bacterial agents (mainly Brucella spp. [brucellosis], Coxiella burnetii [Q fever] and 
Leptospira spp. [leptospirosis]), Typhoid 
–  Protozoal agents (mainly Plasmodium spp [malaria]), leishmaniasis 
3.  To assess whether the impacts of RVF in irrigated areas (Tana River district) differ both 
quantitatively and quantitatively from those observed in a pastoral area (in Ijara district) with 
minimal land use change 
4. To build capacity among the local public and veterinary health service providers on surveillance 
and diagnosis of RVF and related febrile illnesses  
 
The components of the study were also listed as: 
• Hospital based study – Cross-sectional study  
– Systematic random sampling of AFI cases in 4 Health Centres 
 
• Community based study – Cross-sectional study 
– Multi-stage sampling of in each district (Ijara and Tana River) 
– Random selection of households 
 
• Questionnaire surveys  
 
 
Sampling 
Procedures for recruiting subjects and obtaining blood samples were also reviewed in detail. These have 
been described in detail in the proposal. In summary, the points made were: 
• Up to 10 ml venous blood will be collected from all participants using vacutainer needles 
–  Half of this sample will be collected in heparinised vacutainer tubes for pathogen 
identification using targeted multiplex PCR screening  
– The other half will be collected in non-heparinised vacutainer tubes for serum extraction 
for serological analysis 
• Samples will be barcoded and linked to the participant and other metadata 
• The blood and serum samples will be transported in dry ice to ILRI Nairobi where they will be 
kept at -20⁰C until analysed 
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Plate 1. Workshop participants being trained on barcoding blood samples  
2.2 Ethics 
 
The general principles that govern ethics in human health research were discussed; those reviewed 
included: 
• Autonomy – researchers must allow potential subjects make choices. The investigator must 
ensure that: 
–  the participant has received a full disclosure of the nature of the study, the risks, 
benefits and alternatives, with an extended opportunity to ask questions 
• Beneficence -- the investigator must attempt to maximize benefits for the individual participant 
and/or society, while minimizing risk of harm to the individual 
• Justice – equitable selection of participants, benefits or burdens among groups likely to 
participate in research  
 
A conceptual framework for obtaining informed consent published by WHO was used for reference in 
the session (Figure 1). Principles of informed consent were also reviewed as listed below:  
• Disclosure 
– That the individual is invited to participate in the research, reasons for considering the 
individual and that participation is voluntary 
– That the individual is free to refuse to participate, will be free to withdraw without 
penalty or loss of benefits to which he or she will be entitled to 
– The purpose for the research, procedures to be carried out by the investigator and the 
subject and an explanation of how the research differs from routine medical care 
– Features of the research design,  
– Expected duration of the subject’s participation 
– Whether money or other material good will be provided in return for participation 
– Subjects will be informed of research findings in general and individual subjects will be 
informed of any finding that relates to their particular health status 
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– Any foreseeable risks associated with participation in the study 
– Benefits of participation to the society at large 
– How long, where will the samples be stored  
– That treatment will be provided for specific types  of injuries or complications associated 
with the study 
– That an ethical review has cleared the study  
• Understanding 
– The participant must understand what has been explained and must be given an 
opportunity to ask questions 
– Consent form must be written in lay language 
• Voluntariness  
– Participation should be voluntary, free of coercion or promises of benefits  
• Competence 
– Participants must be competent to give consent 
– If not, due to mental illness, disease or emergency, a surrogate may provide consent if it 
is in the best interest for the person to participate 
• Consent 
– Potential subject must authorise his or her participation in the research preferably in 
writing 
– Oral consent may  be given   
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Plate 2. Discussions on the ethics of the study 
 
2.3 Enumerator training  
 
A total of 16 enumerators were identified and invited to the workshop. These were: 
1. Caroline Murimi 
2. Zahra Boch 
3. Lydia Nina 
4. Hasera Raha 
5. Fatuma Osman 
6. Salim Hiribae 
7. Mohamed Guracho 
8. Boba Abdalla 
9. Ahmed Barako 
10. Mustafa Daudi Juge 
11. David Gafo Jillo 
12. Ibrahim Mohamed  Dido 
13. Barre Hussein 
14. Adbdi Elmoge 
15. Mohamed Ali 
16. Dhadho Jillo 
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These enumerators attended the main sessions on the first and the second day on the objectives of the 
DDDAC project, study design, ethics and consenting processes. However on the third, fourth and fifth 
day, they were given specific trainings on the questionnaire administration. The sessions held included: 
- Review of the questionnaire using the hard copies 
- Administration of the questionnaire using the ODK system 
- Pretesting of the questionnaire using the ODK system. 
The program used for these sessions are shown in Table 1.  
Table 1. Program used for the enumerator training 
Date  Activity  Facilitator  Evaluation  
4th  Introduction  
DDDAC objectives and study design 
Dr Bett Questions and answers 
5th  DDDAC study guide  
Barcording and data entry  
Joan  
John and Damaris 
Q/A 
Practical  
6th  Ethics and consenting  
DDDAC cross-sectional questionnaire 
Dr Bett 
John and Damaris 
Q/A 
Q/A 
7th  Questionnaire administration using ODK 
collect  
Jason and Eunice  Practical  
8th  Field visit to administer questionnaire  Jason, Eunice, Millicent, 
Damaris, John, Bett 
Type of data collected  
 
Given that only 10 enumerators were required for the survey based on the availability of the tablets, 6 
were discontinued.  The selection criteria used to select those who were finally hired included ability to 
comprehend their roles and the type of data collected during the pretesting session. They were then 
grouped into two teams as follows:  
Bura and Hola team 
1. Caroline Murimi 
2. Lydia Nina 
3. Mustafa Daudi Juge 
4. Mohamed Guracho  
5. Zahra Boch 
6. David Gafo jillo 
7. Salim Hiribae  
Sangailu and ijara team 
1. Abdi Elmoge 
2. Barre Hussein 
3. Fatuma Osman  
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Millicent Lianni was asked to supervise the team at Bura and Hola while Mohamed Ali the team at 
Sangailu and Ijara. 
 
2.4 Workplan  
A group comprising clinical officers and laboratory technicians sat together on the third and fourth day 
to lay out a strategy for sampling. They suggested that the study should commence with a community 
survey. Teams that were constituted for each site include: 
Bura 
1. Patrick Mbandi 
2. Abdisame Abduahi  
Hola 
1. Said Aden 
2. Said Shushe 
Sangailu and Ijara 
1. Mariam Hamud 
2. Hassan Hussein 
Materials that were required for the survey to commence were listed (Multivitamins, heamatins, 
deworkers, pain killers, antifungal cream, bed nets) 
The team resolved to commence the field work immediately with the hospital survey being postponed 
to February 2014.  
 
 
 
 
 
 
 
 
Plate 3. Development of a survey workplan with clinical officers and laboratory technicians 
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Annex I: Workshop program  
4th Dec 2013 Session Presenter 
0830-0900 General introduction  
0900-0920 Objectives of the workshop Bernard  
0920-1000 DDDAC project  
Design RVF case study 
Cris 
1000-1030 Break  
1030-1050 Opening remarks Director 
1050-1300 RVF case study guide Ian/Joan 
 Lunch  
1400-1700 RVF case study guide Ian/Joan 
5th Dec 2013   
0830-0850 Review of day 1 sessions Ian 
0850-1000 Ethics  Bernard  
1000 - 1030 Break  
1030-1300 Facility/Community questionnaires  Joan/Damaris/John 
1300 - 1400 Lunch   
1400-1500 Facility/Community questionnaires Joan/Damaris/John 
1500 - 1700 Consent forms  Ian/Joan 
6th Dec 2013   
0830 - 0850 Review of day 2 sessions Ian 
0850 - 1100 Work plan  Ian/Bernard 
1400- 1500 Questionnaires/ODK sampling form 
(community survey) 
Jason/Damaris/John 
7th Dec 2013   
0830 - 1300 Field testing  Eunice/Jason 
1400 - 1700 Evaluate field testing responses  Eunice/Jason 
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Annex II: List of participants 
Damaris Mwololo MSc Student, ILRI 22910652 0721275954 
Eunice Kariuki Database manager and Analyst, ILRI 13622741 0726790902 
Jason Rogena Systems Developer, ILRI 28074002 0715023805 
Zablon Jilo Technologist, DVS 8296659 0788228841 
Ibrahim Dido Mohammed Enumerator 27585568 0721820447 
Lokapel L. Mark Medical Officer, MPH 20673253 0727994508 
Barako Ahmed Enumerator 27797320 0727958277 
Mohamed Mohamud Guracho Enumerator 25339762 0720839892 
Joan Karanja Medical Epidemiologist, MPH 22484964 0722421524 
John Muriuki MSC student, ILRI 25795594 0725773661 
Bobba A. Boru Enumerator 26696742 0726375721 
Saeed Adan Lab Technologist, MPH 23713287 0720963523 
Mustafa J. Daud Enumerator 27932598 0711108861 
Zahra Boch Abarea Enumerator 24157895 0715079335 
Peter Lokamar Medical Epidemiologist, MPH 10125677 0722447176 
Stephen Kitundu Lab Technologist, MPH 20034990 0727771582 
Godfrey Mutua Lab Technologist, MPH 22299980 0726578836 
Johnson Dhadho Hiribae Enumerator 23367391 0726806940 
Said Shushe Wario Lab Technician, MPH 8297570 0735820388 
Fatma Osman Enumerator 27511944 0728471133 
Maryan Hamud Lab Technician, MPH 27777415 0727337769 
Abdisamet Abdullahi Lab Technician, MPH 13701515 0722507062 
Salim Hiribae Enumerator 24793982 0710521742 
Caroline M. Murimi Enumerator 27446504 0717589403 
Patrick Mbandi Lab Technician 24006593 0720345797 
Raha Hasera Verna Enumerator 28593983 0727503455 
David Gafo Jillo Enumerator 25885702 0723857537 
Lydia Hadia Hiribae Enumerator 28968263 0714892088 
Hassan Abdi Mohammed Lab Technologist, MPH 0035997 0722918439 
Hassan Hussein Chief Lab  0540237 0724179083 
Titus Mutai Medical Officer, MPH 25194559 0724043980 
Bernard Bett Epidemiologist, ILRI 11204477 0722841938 
 
